JP2023547441A5 - - Google Patents
Info
- Publication number
- JP2023547441A5 JP2023547441A5 JP2023526007A JP2023526007A JP2023547441A5 JP 2023547441 A5 JP2023547441 A5 JP 2023547441A5 JP 2023526007 A JP2023526007 A JP 2023526007A JP 2023526007 A JP2023526007 A JP 2023526007A JP 2023547441 A5 JP2023547441 A5 JP 2023547441A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidine
- compound
- methyl
- nitrooxy
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20205111 | 2020-11-02 | ||
| EP20205111.6 | 2020-11-02 | ||
| PCT/EP2021/079958 WO2022090379A1 (en) | 2020-11-02 | 2021-10-28 | No-pde5 inhibitor for use in treating dry age-related macular degeneration, geographic atrophy and glaucoma-associated neurodegeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547441A JP2023547441A (ja) | 2023-11-10 |
| JP2023547441A5 true JP2023547441A5 (enExample) | 2024-10-29 |
Family
ID=73043154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526007A Pending JP2023547441A (ja) | 2020-11-02 | 2021-10-28 | 萎縮型加齢黄斑変性、地図状萎縮および緑内障関連神経変性の処置において使用するためのｎｏ－ｐｄｅ５阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230414621A1 (enExample) |
| EP (1) | EP4236952A1 (enExample) |
| JP (1) | JP2023547441A (enExample) |
| CN (1) | CN116456963A (enExample) |
| WO (1) | WO2022090379A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026142247A1 (ko) * | 2024-12-23 | 2026-07-02 | 뉴로비비 주식회사 | 피롤로피리미디논 유도체 및 이를 유효성분으로 포함하는 약학적 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137429A0 (en) * | 1999-07-28 | 2001-07-24 | Pfizer Prod Inc | Methods and compsitions for treating diseases and conditions of the eye |
| US20020168424A1 (en) | 2002-07-31 | 2002-11-14 | Dr. Mohsen Shahinpoor | Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma |
| JP6850734B2 (ja) | 2015-05-27 | 2021-03-31 | ニューロテック ユーエスエー， インコーポレイテッド | 眼の障害の処置のためのカプセル化細胞療法の使用 |
| KR102862562B1 (ko) | 2015-11-16 | 2025-09-19 | 토파두르 파마 아게 | 포스포디에스테라제 억제제로서 2-페닐-3,4-디하이드로피롤로[2,1-f][1,2,4]트리아지논 유도체 및 이의 용도 |
| WO2017176770A1 (en) | 2016-04-04 | 2017-10-12 | The Schepens Eye Research Institute, Inc. | Peroxisome proliferator-activated receptor gamma selective agonists for inhibition of retinal pigment epithelium degeneration or geographic atrophy |
| EP3630769B1 (en) | 2017-05-22 | 2025-07-02 | Topadur Pharma AG | Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof |
| CN112566670B (zh) | 2018-08-06 | 2024-11-12 | 尼科斯股份有限公司 | 一氧化氮释放第5型磷酸二酯酶抑制剂 |
| EP3887376A1 (en) * | 2018-11-28 | 2021-10-06 | Topadur Pharma AG | Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof |
| ES2969139T3 (es) * | 2020-02-05 | 2024-05-16 | Nicox Sa | Composiciones para el tratamiento del glaucoma e hipertensión ocular |
-
2021
- 2021-10-28 WO PCT/EP2021/079958 patent/WO2022090379A1/en not_active Ceased
- 2021-10-28 US US18/251,283 patent/US20230414621A1/en active Pending
- 2021-10-28 JP JP2023526007A patent/JP2023547441A/ja active Pending
- 2021-10-28 CN CN202180074083.7A patent/CN116456963A/zh active Pending
- 2021-10-28 EP EP21805410.4A patent/EP4236952A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105307498B (zh) | 用于治疗眼病的组合物、制剂和方法 | |
| US12162871B2 (en) | Inhibitors of VAP-1 | |
| RU2009148137A (ru) | Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств | |
| JP2020125355A (ja) | 併用療法 | |
| JP7192049B2 (ja) | 眼科用組成物 | |
| JP2022081661A5 (enExample) | ||
| DK2888239T3 (en) | REDUCED CENTRAL CORCHET THICKENING USING HYDROFILE ESTER PRODUGS OF BETA-CHLORCYCLOPENTANE | |
| CN101678107A (zh) | 用于治疗杜兴型肌营养不良的药物组合物 | |
| CN101743009A (zh) | 治疗干眼病的药物组合物和方法 | |
| CN110343135A (zh) | 替诺福韦艾拉酚胺(tenofovir alafenamide)半反丁烯二酸盐 | |
| JP2021533152A5 (enExample) | ||
| JP2004502670A5 (enExample) | ||
| ES2349470T3 (es) | Nuevos beta-2-agonistas de acción de larga duración y su utilización como medicamentos. | |
| CN112566670A (zh) | 一氧化氮释放第5型磷酸二酯酶抑制剂 | |
| JP2022530322A5 (enExample) | ||
| US12479866B2 (en) | Boron-containing rho kinase inhibitors | |
| US10537563B2 (en) | Methods for treating ocular disease using inhibitors of CSF-1R | |
| RU2007136602A (ru) | Применение модуляторов рецептора s1p в офтальмологии | |
| CN105283452A (zh) | 新的四唑酮衍生物 | |
| JP2021113185A (ja) | βアミノ酸誘導体、これを含むキナーゼ阻害剤および医薬組成物ならびにその使用 | |
| DK3107906T3 (en) | REDUCED CENTRAL CORNER MAP THICKNESS USING HYDROFILE ESTER PRODRUGS OF BETA-CHLORCYCLOPENTANE | |
| ES2686675T3 (es) | Agente terapéutico para enfermedad ocular | |
| JP2006527735A (ja) | ジフェニル尿素誘導体、及びクロライドチャネル遮断剤としてのそれらの使用 | |
| US10335417B2 (en) | Thiazideamide derivative and use thereof | |
| EP4686472A1 (en) | Cxcl8 inhibitors for use in the treatment of ocular graft-versus-host disease |